Status:
TERMINATED
Does Intravenous Cannabis Reduce Postoperative Nausea and Vomiting (PONV)?
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Nausea
Vomiting
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The investigators evaluate if intravenously applied THC (Cannabis) reduces postoperative Nausea and vomiting. THC will be given during anesthesia before emergence. We measure how long and how effectiv...
Eligibility Criteria
Inclusion
- ASA I-III
- elective open and laparoscopic surgery \>1hour
Exclusion
- ambulatory surgery
- pregnancy, breast feeding
- \>ASA III
- BMI \>35
- antipsychotic, antiemetic, cytostatic therapy
- major cardiovascular, renal, hepatic, central nervous system disease
- current chronic cannabis consumption and hard drug abuse
- schizophrenia
- preoperative nausea and vomiting, vestibular disease
- not speaking german or french
- refusal to participate
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00695487
Start Date
July 1 2008
End Date
December 1 2011
Last Update
March 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital, Bern University Hospital
Bern, Canton of Bern, Switzerland, 3010